Oscar Health (NYSE:OSCR) Stock Price Down 5.7% – Time to Sell?

Oscar Health, Inc. (NYSE:OSCR) traded down 5.7% during mid-day trading on Tuesday . The company traded as low as $17.03 and last traded at $17.05. 647,633 shares were traded during trading, a decline of 80% from the average session volume of 3,208,691 shares. The stock had previously closed at $18.09.

Analysts Set New Price Targets

A number of equities analysts have commented on the company. UBS Group assumed coverage on Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price objective on the stock. Piper Sandler reissued an “overweight” rating and issued a $28.00 price target on shares of Oscar Health in a report on Tuesday, September 10th. Three investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Oscar Health presently has an average rating of “Moderate Buy” and an average price target of $24.00.

Oscar Health Price Performance

The company has a market cap of $4.30 billion, a P/E ratio of -131.07, a PEG ratio of 34.96 and a beta of 1.67. The company has a fifty day moving average price of $18.74 and a two-hundred day moving average price of $18.43. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.91 and a current ratio of 0.91.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Wednesday, August 7th. The company reported $0.20 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.04. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The company had revenue of $2.20 billion during the quarter, compared to the consensus estimate of $2.13 billion. During the same period in the previous year, the business earned ($0.07) earnings per share. The firm’s quarterly revenue was up 44.6% on a year-over-year basis. On average, sell-side analysts anticipate that Oscar Health, Inc. will post 0.01 earnings per share for the current fiscal year.

Insider Activity

In related news, EVP Alessandrea C. Quane sold 16,793 shares of Oscar Health stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $17.06, for a total value of $286,488.58. Following the sale, the executive vice president now owns 392,607 shares of the company’s stock, valued at approximately $6,697,875.42. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, EVP Alessandrea C. Quane sold 16,793 shares of the stock in a transaction on Friday, September 6th. The shares were sold at an average price of $17.06, for a total value of $286,488.58. Following the transaction, the executive vice president now owns 392,607 shares of the company’s stock, valued at $6,697,875.42. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Richard Scott Blackley sold 29,957 shares of the company’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $17.06, for a total transaction of $511,066.42. Following the completion of the sale, the chief financial officer now directly owns 853,875 shares of the company’s stock, valued at $14,567,107.50. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 169,569 shares of company stock valued at $3,007,069. 25.11% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Oscar Health

Several institutional investors have recently added to or reduced their stakes in the company. Quantbot Technologies LP boosted its position in Oscar Health by 435.5% in the first quarter. Quantbot Technologies LP now owns 14,495 shares of the company’s stock worth $216,000 after purchasing an additional 11,788 shares during the last quarter. Oppenheimer & Co. Inc. grew its stake in shares of Oscar Health by 20.8% during the 1st quarter. Oppenheimer & Co. Inc. now owns 19,450 shares of the company’s stock worth $289,000 after purchasing an additional 3,350 shares during the period. Avalon Trust Co purchased a new stake in shares of Oscar Health in the 1st quarter valued at approximately $69,000. Swiss National Bank raised its stake in Oscar Health by 2.4% during the 1st quarter. Swiss National Bank now owns 263,800 shares of the company’s stock worth $3,923,000 after acquiring an additional 6,100 shares in the last quarter. Finally, Susquehanna Fundamental Investments LLC grew its stake in shares of Oscar Health by 14.9% in the 1st quarter. Susquehanna Fundamental Investments LLC now owns 51,780 shares of the company’s stock valued at $770,000 after purchasing an additional 6,733 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.